Skip to content
Back to search

NCT06936774Recruiting

Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance

Summary

The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visits and medical treatment, pelvic floor muscle training and gynaecological and urological co-treatment in case of LARS symptoms and urinary or sexual complaints.

Inclusion criteria

• patients older than 18 years • patients with rectal cancer in the middle and lower third of the rectum in stages I to IV who underwent LAR with TME and protective ileostomy • able to give informed consent as documented by signature

Exclusion criteria

• dementia or other psychiatric disorder that would prevent the patients from answering the questionnaires and experiencing sustainable training effects • impossibility of stoma reversal due to persistent anastomotic leak and/or local recurrence

Contacts

The trial team's contact details are shown on request.

See the official trial record
Status
Recruiting
Phase
Phase 3
Study type
Interventional
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland(Other)
Protocol no.
iRECOVER_2025
Conditions
LARS - Low Anterior Resection Syndrome, Rectal Cancer Surgery, Rectal Cancer, Quality of Life (QOL)
Interventions
Other

Treatments studied

  • Intensified follow-up program

Collaborators

St. Claraspital AG, Clarunis - Universitäres Bauchzentrum Basel

Locations · 4

  • Basel, SwitzerlandClarunis Universitäres Bauchzentrum BaselRecruiting at this site
  • Bern, SwitzerlandLindenhofspital BernRecruiting at this site
  • Lucerne, SwitzerlandKantonsspital LuzernRecruiting at this site
  • Winterthur, SwitzerlandKantonsspital WinterthurRecruiting at this site

In total, worldwide, 4 of the 5 sites listed in the registry are recruiting; the other one is not currently recruiting.

Site status per the ClinicalTrials.gov registry (last update posted: May 6, 2026).

This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.

See also

Other versions

These results are indicative and do not replace medical advice — discuss them with your doctor.